Literature DB >> 17161332

Gonadotrophin resistance.

Ilpo Huhtaniemi1, Maria Alevizaki.   

Abstract

Gonadotrophin resistance is caused by inactivating mutations in receptors (Rs) of the two gonadotrophins, i.e. luteinizing hormone (LH) and follicle-stimulating hormone (FSH), presenting as hypergonadotrophic hypogonadism and infertility/subfertility in both sexes. These conditions are extremely rare, but must be kept in mind upon differential diagnosis of disorders of sexual maturation, hypogonadism and infertility. In 46,XY individuals inactivation of LHR causes a disturbance in male-type sexual differentiation that ranges from male pseudohermaphroditism (complete lack of genital masculinization) to mild conditions such as cryptorchidism and hypospadias, depending on completeness of the receptor inactivation. In women, the phenotype is milder, presenting mainly as anovulatory amenorrhoea and hypo-oestrogenization. Inactivation of FSHR causes in otherwise normally masculinized men small testis size and variably reduced spermatogenesis, but not azoospermia or absolute infertility. In women the phenotype is more severe, with primary or early secondary amenorrhoea, arrested follicular maturation and anovulatory infertility. Incomplete forms with milder phenotype and partial responsiveness to FSH have also been described. Although gonadotrophin resistance is a very rare condition, its correct diagnosis is important for the selection of adequate treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17161332     DOI: 10.1016/j.beem.2006.09.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  13 in total

1.  Successful testicular sperm recovery and IVF treatment in a man with Leydig cell hypoplasia.

Authors:  M E Bakircioglu; P Tulay; N Findikli; B Erzik; M Gultomruk; M Bahceci
Journal:  J Assist Reprod Genet       Date:  2014-05-03       Impact factor: 3.412

2.  Rescue of expression and signaling of human luteinizing hormone G protein-coupled receptor mutants with an allosterically binding small-molecule agonist.

Authors:  Claire L Newton; Adele M Whay; Craig A McArdle; Meilin Zhang; Chris J van Koppen; Ruud van de Lagemaat; Deborah L Segaloff; Robert P Millar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

3.  Alterations of the FSH and LH receptor genes and evaluation of sperm ultrastructure in men with idiopathic hypergonadotropic hypogonadism.

Authors:  G Collodel; S Cantara; G Di Cairano; E Moretti; S Taglianetti; Furio Pacini
Journal:  J Assist Reprod Genet       Date:  2013-07-25       Impact factor: 3.412

4.  Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome.

Authors:  Nana Liu; Yanmin Ma; Shuyu Wang; Xiaowei Zhang; Qiufang Zhang; Xue Zhang; Li Fu; Jie Qiao
Journal:  Reprod Biol Endocrinol       Date:  2012-04-30       Impact factor: 5.211

Review 5.  Delayed and Precocious Puberty: Genetic Underpinnings and Treatments.

Authors:  Anisha Gohil; Erica A Eugster
Journal:  Endocrinol Metab Clin North Am       Date:  2020-12       Impact factor: 4.741

6.  The live birth in a woman with resistant ovary syndrome after in vitro oocyte maturation and preimplantation genetic testing for aneuploidy.

Authors:  Nikolay Valerievich Kornilov; Marina Nikolaevna Pavlova; Pavel Pavlovich Yakovlev
Journal:  J Assist Reprod Genet       Date:  2021-01-26       Impact factor: 3.357

7.  The luteinizing hormone beta-subunit exon 3 (Gly102Ser) gene mutation and ovarian responses to controlled ovarian hyperstimulation.

Authors:  Robab Davar; Nasim Tabibnejad; Seyed Mehdi Kalantar; Mohammad Hasan Sheikhha
Journal:  Iran J Reprod Med       Date:  2014-10

8.  The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency.

Authors:  Birgit Köhler; Lin Lin; Inas Mazen; Cigdem Cetindag; Heike Biebermann; Ilker Akkurt; Rainer Rossi; Olaf Hiort; Annette Grüters; John C Achermann
Journal:  Eur J Endocrinol       Date:  2009-05-13       Impact factor: 6.664

Review 9.  Perspectives on the development and future of oocyte IVM in clinical practice.

Authors:  Michel De Vos; Michaël Grynberg; Tuong M Ho; Ye Yuan; David F Albertini; Robert B Gilchrist
Journal:  J Assist Reprod Genet       Date:  2021-07-03       Impact factor: 3.412

Review 10.  Similar causes of various reproductive disorders in early life.

Authors:  Konstantin Svechnikov; Jan-Bernd Stukenborg; Iuliia Savchuck; Olle Söder
Journal:  Asian J Androl       Date:  2014 Jan-Feb       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.